ISDS Case Map
intellectual property
Amid fresh talks on the India-Japan free trade agreement (FTA), concerns are being expressed about certain measures that could hamper generic drugs and access to medicines.
A review of market access barriers faced by Indian exporters in its major trading partners and other select countries, 24 in all.
The European Union on Friday said it would prefer to resolve two commercial disputes with India without engaging in a legal battle at the World Trade Organisation (WTO). The first dispute involves seizure of Indian generic drugs in transit at some EU-based ports, including Amsterdam, which were bound for certain third world countries, on the grounds of patents infringement.
The Central America Free Trade Agreement has kept some generic drugs from Guatemala
even though they're available in the United States.
The recent patenting of a Thai rice gene will pave the way for overseas firms to obtain copyrights of Thai biological and genetic resources, intellectual property rights experts and farmer advocates warn.
The European Union's demands on India to take on higher intellectual property (IP) standards, if adopted, could spell disaster for the supply of low-cost generic medicines, undermine India's development and set a significant precedent for the future of IPR protection globally, cautioned Dr Carlos M. Correa, an expert on IP and the WTO TRIPS Agreement.
What is slowly emerging is the beginning of a composite oppositition to FTAs in India.
The negotiating texts so far known do indicate that India is resisting many aspects of the EU demands of higher IPRs standards. Analysis by Carlos Correa.
The US Trade Representative has finally finished the long overdue task of relaunching its website.
The US-Israel Free Trade Area became law in 1985, but ongoing violations of American intellectual property rights and trade laws are fueling heavy losses of American jobs. As the US economy declines many are trying to separate myths from facts about America's first bilateral trade agreement.
